Skip to main content.

Michael G. Abraham, MD

Michael Abraham portrait
Professor, Neurology

Stroke Research Director, SOM-Kansas City, Neurology

mabraham@kumc.edu

Professional Background

Dr. Abraham is an associate professor in Neurointerventional Surgery and Neurocritical Care, in the departments of Neurology and Radiology. He received his doctor of medicine degree from the University of Missouri-Kansas City in 2005. He completed his neurology residency at the University of Kansas in 2009. Following this, he began an accelerated three-year training fellowship in Neurointerventional Surgery and Neurocritical Care at the Medical College of Wisconsin, where he performed over 700 neurointerventional cases.

Dr. Abraham joined the faculty at the University of Kansas in August 2012 in the Neurology department as an assistant clinical professor. He is board certified in Neurology, Neurocritical Care and has completed a fellowship in Neurointerventional Surgery.

His neurointerventional services include aneurysm coiling/flow diversion, endovascular stroke treatment, tumor embolization, AVM/AVF embolization, cerebral and spinal angiograms, WADA tests, carotid stenting/angioplasty, intracranial stenting/angioplasty, subdural hemorrhage middle meningeal artery embolization, and intracranial venous stenting/angioplasty. His neurocritical care focus includes, but is not limited to, subarachnoid hemorrhages, intracranial hemorrhages, traumatic brain injury, stroke and intracranial hypertension.

Education and Training
  • MD, Medicine, University of Missouri-Kansas City
  • BA, Liberal arts, University of Missouri-Kansas City
  • Internship, Internal Medicine, University of Missouri-Kansas City, Kansas City, MO
  • Residency, Neurology, University of Kansas, Kansas City, KS
  • Clinical Fellowship, Neurocritical Care, Medical College of Wisconsin, Milwaukee, WI
  • Clinical Fellowship, Interventional Neurology, Medical College of Wisconsin, Milwaukee, WI
Licensure, Accreditations & Certifications
  • Kansas Board of Healing Arts
  • Neurocritical Care, United Council for Neurological Subspecialties
  • Neurology, American Board of Psychiatry and Neurology
Professional Affiliations
  • American Academy of Neurology, Member, 2019 - Present
  • Association of Indian Neurologists in America, Member, 2019 - Present
  • Foundations of Interprofessional Collaboration: Introduction to Team STEPPS Facilitator, KUMC Level Three, Foundations of Interprofessional Collaboration: Introduction to Team STEPPS Facilitator, KUMC Level Three, Facilitator, 2018 - 2018
  • American Heart Association Stroke Council, Fellow, 2016 - Present
  • Neurocritical Care Society, Member, 2009 - Present
  • Society of Vascular and Interventional Neurology , Member, 2009 - Present
  • Neurology Resident's Council, Member, 2006 - 2007

Research

Overview

I have been director of stroke research since 2017. I oversee multiple international, national, and local research projects that our team is involved in and am the site investigator on multiple clinical trials. One trial that I was the site investigator on, the DAWN trial, helped changed the updated 2018 acute stroke guidelines, extending endovascular stroke treatment up to 24 hours. Current trials that we are involved in are: SELECT 2, TIMELESS, CHARM, MASTERS 2, MOST, SATURN, PICASSO, and ASSIST.

Projects that I oversee at the hospital level include, but are not limited to, venous stenting for idiopathic intracranial hypertension/pseudotumor cerebri, stroke, emergent carotid artery stenting, aneurysmal subarachnoid hemorrhage, and vasospasm. I mentor our stroke fellow, multiple residents, medical students, and undergraduate pre-med students in research projects. Our manuscripts and abstracts have been accepted in national and international conferences and many have been published.

I work closely with our Physical Therapy and Rehabilitation Science team, Neurosurgery team, and Radiology team in multiple research collaborations.

Current Research and Grants
  • SELECT 2, UT Houston/Stryker, Site-PI
Publications
  • Nogueira, RG, Jadhav, AP, Haussen, DC, Bonafe, A, Cognard, C, Hanel, RA, Sila, CA, Hassan, AE, Millab, M, Levy, EI, Mitchell, P, Chen, M, English, JD, Shah, QA, Silver, FL, Pereira, VM, Mehta, BR, Baxter, BW, Abraham, MG, Cardona, P, Veznedaroglu, E, Hellinger, FR, Feng, L, Kirmani, JF, Lopes, DK, Jankowitz, BT, Frankel, MR, Costalat, V, Vora, NA, Yoo, AJ, Malik, AM, Furlan, AJ, Rubiera, M, Aghaebrahim, A, Olivot, JM, Tekle, WG, Shields, R, Graves, T, Lewis, RJ, Smith, WS, Liebeskind, DS, Saver, JL, Jovin, TG, for the DAWN Trial Investigators. 2017. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med
  • Gordon, W, Abraham, M. 2020. Contralateral approach to transverse-sigmoid sinus stenting.. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 1591019920954940
  • Sarraj, A, Hassan, A., E, Grotta, J, Sitton, C, Cutter, G, Cai, C, Chen, P., R, Imam, B, Pujara, D, Arora, A, Reddy, S, Parsha, K, Riascos, R., F, Vora, N, Abraham, M, Edgell, R, Hellinger, F, Haussen, D., C, Blackburn, S, Kamal, H, Barreto, A., D, Martin-Schild, S, Lansberg, M, Gupta, R, Savitz, S, Albers, G., W. 2020. Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection.. Annals of neurology